TransEnterix (NYSE:TRXC) said yesterday that it submitted an application for 510(k) clearance from the FDA for its SurgiBot robot-assisted surgery device. Research Triangle Park, N.C.-based TransEnterix claims the SurgiBot as the 1st patient-side robotically enhanced laparoscopy platform, designed to be wheeled to a patient’s bedside. "TransEnterix is pleased to deliver on our commitment to file […]
TransEnterix
Ex-Stryker CFO Hartman wins CEO job at ConMed | Personnel Moves
SafeStitch Medical takes TransEnterix’s name
Florida medical device maker SafeStitch Medical was reborn as TransEnterix Inc. as the companies navigated a previously announced merger.
SafeStitch shareholders approved a restated certificate of incorporation, under which the company took TransEnterix’s name more than tripled the number of authorized shares of common stock from 225 million to 750 million, according to regulatory documents.
SafeStitch Medical to merge with TransEnterix, raise $30M
SafeStitch Medical (OTC:SFES) and TransEnterix are set to merge next quarter in a deal that includes a private placement worth about $30 million.